Company: QXO-PB
Filing Date: 2025-04-18
Form Type: 424B5
Source: 0001140361-25-014566
Chunk: 23

Company: QXO, Inc.
Filing Date: 2025-04-18
Form: 424B5
Chunk 23
---
 resale of 789,549,465 shares of Common Stock held by, or issuable upon conversion or exercise of securities held by, stockholders party to certain agreements with QXO providing them with registration rights. In addition, we have agreed to file a prospectus supplement within 30 days following the closing of the Acquisition to register the resale of 67,528,459 shares of Common Stock we agreed to sell to certain investors in the Private Placement. Substantial sales of securities by these stockholders and investors, or the perception that substantial sales will be made in the public market, could have a material adverse effect on the market price for our Common Stock.

S-13

#### TABLE OF CONTENTS
**In addition, pursuant to QXO’s registration rights agreement with Jacobs Private Equity II, LLC (“JPE”) and certain other investors party thereto, JPE has certain demand registration rights that may require us to conduct underwritten offerings of shares. Any shares of Common Stock sold in these offerings will be freely tradable. In the event such registration rights are exercised and a large number of shares of Common Stock is sold, such sales could reduce the trading price of our Common Stock. These sales also could impede our ability to raise future capital.

We have also registered on Form S-8 all shares of Common Stock that are issuable under our 2024 Omnibus Incentive Compensation Plan. In addition, we plan to register on Form S-8 all shares of Common Stock that are issuable upon the exercise and/or vesting of equity awards expected to be granted in connection with the Acquisition to replace certain outstanding Beacon awards. As a consequence, these shares can be freely sold in the public market upon issuance. Any sales of shares by these stockholders could have a negative impact on the trading price of our Common Stock and result in dilution.

An active, liquid trading market for our Common Stock may not develop or, if developed, may not be sustained.

There has been limited trading volume of our Common Stock since we began trading on Nasdaq and, following the transfer of our listing in January 2025, the NYSE. An active, liquid trading market for our Common Stock may not be sustained. The lack of an active market may reduce the market price of our Common Stock, and you may not be able to sell your shares at an attractive price, or at all. An inactive market may also impair our ability to raise capital by selling shares of our Common Stock in the future and may impair our ability to enter